Variant report
Variant | nsv606198 |
---|---|
Chromosome Location | chr7:11316581-11330387 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:11317077..11318618-chr7:11320125..11322658,2 | K562 | blood: | |
2 | chr7:11325170..11327885-chr7:11339729..11342510,2 | K562 | blood: | |
3 | chr7:10977336..10979714-chr7:11321113..11323195,2 | K562 | blood: | |
4 | chr7:11328573..11331475-chr7:11331531..11334464,2 | K562 | blood: | |
5 | chr7:11327180..11330030-chr7:11331702..11333462,2 | K562 | blood: | |
6 | chr7:11317077..11318618-chr7:11320125..11322658,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000189043 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11765838 | chr7:11316581-11316582 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs182112734 | chr7:11316588-11316589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186581277 | chr7:11316614-11316615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560966459 | chr7:11316632-11316633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17164202 | chr7:11316728-11316729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112843097 | chr7:11316743-11316744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117003887 | chr7:11316772-11316773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200023607 | chr7:11316775-11316776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531998850 | chr7:11316791-11316792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551829550 | chr7:11316800-11316801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568617789 | chr7:11316827-11316828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10262329 | chr7:11316836-11316837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs368954283 | chr7:11316861-11316862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150308854 | chr7:11316868-11316869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372782559 | chr7:11316879-11316880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557846397 | chr7:11316903-11316904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568586981 | chr7:11316906-11316907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75899415 | chr7:11316927-11316928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554183440 | chr7:11316930-11316931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533876020 | chr7:11316956-11316957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114405340 | chr7:11316975-11316976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184022933 | chr7:11317027-11317028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17164205 | chr7:11317059-11317060 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs576602119 | chr7:11317088-11317089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs67994626 | chr7:11317092-11317093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35754622 | chr7:11317100-11317101 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs12671628 | chr7:11317113-11317114 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs540487904 | chr7:11317120-11317121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115638317 | chr7:11317122-11317123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188967663 | chr7:11317192-11317193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73069491 | chr7:11317196-11317197 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs113736124 | chr7:11317247-11317248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562188860 | chr7:11317271-11317272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143792672 | chr7:11317272-11317273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79293459 | chr7:11317352-11317353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373814933 | chr7:11317405-11317406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17541593 | chr7:11317410-11317411 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs534150637 | chr7:11317426-11317427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77871592 | chr7:11317443-11317444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571170255 | chr7:11317448-11317449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540176726 | chr7:11317462-11317463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111286089 | chr7:11317463-11317464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576535785 | chr7:11317464-11317465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142920141 | chr7:11317480-11317481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145101626 | chr7:11317489-11317490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73293723 | chr7:11317495-11317496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7796369 | chr7:11317530-11317531 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs553589088 | chr7:11317537-11317538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs193023271 | chr7:11317562-11317563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545719138 | chr7:11317577-11317578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11309800-11317200 | Weak transcription | Liver | Liver |
2 | chr7:11315800-11316600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr7:11315800-11316800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr7:11316000-11316600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr7:11316400-11316800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr7:11316400-11318000 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr7:11316600-11318200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr7:11316800-11318000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr7:11318000-11318400 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr7:11318000-11318400 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr7:11318000-11319000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr7:11318200-11318600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr7:11318200-11319200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr7:11321200-11321400 | Enhancers | K562 | blood |
15 | chr7:11321400-11322000 | Flanking Active TSS | K562 | blood |
16 | chr7:11322000-11322400 | Enhancers | K562 | blood |
17 | chr7:11327400-11328800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr7:11327400-11328800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr7:11328000-11328600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
20 | chr7:11328000-11328800 | Enhancers | Primary monocytes fromperipheralblood | blood |
21 | chr7:11328400-11328600 | Enhancers | Pancreas | Pancrea |
22 | chr7:11329400-11329600 | Enhancers | Pancreas | Pancrea |